Evaluation of Diabetes Care Performance in Cambodia Through the Cascade-of-Care Framework: Cross-Sectional Study.
care continuum
cascade of care
diabetes
implementation research
mobile phone
population-based survey
Journal
JMIR public health and surveillance
ISSN: 2369-2960
Titre abrégé: JMIR Public Health Surveill
Pays: Canada
ID NLM: 101669345
Informations de publication
Date de publication:
22 Jun 2023
22 Jun 2023
Historique:
received:
14
08
2022
accepted:
08
05
2023
revised:
28
03
2023
medline:
26
6
2023
pubmed:
22
6
2023
entrez:
22
6
2023
Statut:
epublish
Résumé
Cambodia has seen an increase in the prevalence of type 2 diabetes (T2D) over the last 10 years. Three main care initiatives for T2D are being scaled up in the public health care system across the country: hospital-based care, health center-based care, and community-based care. To date, no empirical study has systematically assessed the performance of these care initiatives across the T2D care continuum in Cambodia. This study aimed to assess the performance of the 3 care initiatives-individually or in coexistence-and determine the factors associated with the failure to diagnose T2D in Cambodia. We used a cascade-of-care framework to assess the T2D care continuum. The cascades were generated using primary data from a cross-sectional population-based survey conducted in 2020 with 5072 individuals aged ≥40 years. The survey was conducted in 5 operational districts (ODs) selected based on the availability of the care initiatives. Multiple logistic regression analysis was used to identify the factors associated with the failure to diagnose T2D. The significance level of P<.05 was used as a cutoff point. Of the 5072 individuals, 560 (11.04%) met the definition of a T2D diagnosis (fasting blood glucose level ≥126 mg/dL and glycated hemoglobin level ≥6.5%). Using the 560 individuals as the fixed denominator, the cascade displayed substantial drops at the testing and control stages. Only 63% (353/560) of the participants had ever tested their blood glucose level in the last 3 years, and only 10.7% (60/560) achieved blood glucose level control with the cutoff point of glycated hemoglobin level <8%. The OD hosting the coexistence of care displayed the worst cascade across all bars, whereas the OD with hospital-based care had the best cascade among the 5 ODs. Being aged 40 to 49 years, male, and in the poorest category of the wealth quintile were factors associated with the undiagnosed status. The unmet needs for T2D care in Cambodia were large, particularly in the testing and control stages, indicating the need to substantially improve early detection and management of T2D in the country. Rapid scale-up of T2D care components at public health facilities to increase the chances of the population with T2D of being tested, diagnosed, retained in care, and treated, as well as of achieving blood glucose level control, is vital in the health system. Specific population groups susceptible to being undiagnosed should be especially targeted for screening through active community outreach activities. Future research should incorporate digital health interventions to evaluate the effectiveness of the T2D care initiatives longitudinally with more diverse population groups from various settings based on routine data vital for integrated care. International Standard Randomized Controlled Trials Number (ISRCTN) ISRCTN41932064; https://www.isrctn.com/ISRCTN41932064. RR2-10.2196/36747.
Sections du résumé
BACKGROUND
BACKGROUND
Cambodia has seen an increase in the prevalence of type 2 diabetes (T2D) over the last 10 years. Three main care initiatives for T2D are being scaled up in the public health care system across the country: hospital-based care, health center-based care, and community-based care. To date, no empirical study has systematically assessed the performance of these care initiatives across the T2D care continuum in Cambodia.
OBJECTIVE
OBJECTIVE
This study aimed to assess the performance of the 3 care initiatives-individually or in coexistence-and determine the factors associated with the failure to diagnose T2D in Cambodia.
METHODS
METHODS
We used a cascade-of-care framework to assess the T2D care continuum. The cascades were generated using primary data from a cross-sectional population-based survey conducted in 2020 with 5072 individuals aged ≥40 years. The survey was conducted in 5 operational districts (ODs) selected based on the availability of the care initiatives. Multiple logistic regression analysis was used to identify the factors associated with the failure to diagnose T2D. The significance level of P<.05 was used as a cutoff point.
RESULTS
RESULTS
Of the 5072 individuals, 560 (11.04%) met the definition of a T2D diagnosis (fasting blood glucose level ≥126 mg/dL and glycated hemoglobin level ≥6.5%). Using the 560 individuals as the fixed denominator, the cascade displayed substantial drops at the testing and control stages. Only 63% (353/560) of the participants had ever tested their blood glucose level in the last 3 years, and only 10.7% (60/560) achieved blood glucose level control with the cutoff point of glycated hemoglobin level <8%. The OD hosting the coexistence of care displayed the worst cascade across all bars, whereas the OD with hospital-based care had the best cascade among the 5 ODs. Being aged 40 to 49 years, male, and in the poorest category of the wealth quintile were factors associated with the undiagnosed status.
CONCLUSIONS
CONCLUSIONS
The unmet needs for T2D care in Cambodia were large, particularly in the testing and control stages, indicating the need to substantially improve early detection and management of T2D in the country. Rapid scale-up of T2D care components at public health facilities to increase the chances of the population with T2D of being tested, diagnosed, retained in care, and treated, as well as of achieving blood glucose level control, is vital in the health system. Specific population groups susceptible to being undiagnosed should be especially targeted for screening through active community outreach activities. Future research should incorporate digital health interventions to evaluate the effectiveness of the T2D care initiatives longitudinally with more diverse population groups from various settings based on routine data vital for integrated care.
TRIAL REGISTRATION
BACKGROUND
International Standard Randomized Controlled Trials Number (ISRCTN) ISRCTN41932064; https://www.isrctn.com/ISRCTN41932064.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
RR2-10.2196/36747.
Identifiants
pubmed: 37347529
pii: v9i1e41902
doi: 10.2196/41902
pmc: PMC10337437
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e41902Informations de copyright
©Vannarath Te, Srean Chhim, Veerle Buffel, Wim Van Damme, Josefien van Olmen, Por Ir, Edwin Wouters. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 22.06.2023.
Références
Mhealth. 2020 Oct 05;6:40
pubmed: 33437836
Int J Nurs Stud. 2021 Apr;116:103286
pubmed: 30827741
Prim Care Diabetes. 2015 Jun;9(3):196-202
pubmed: 25281167
J Eval Clin Pract. 2013 Oct;19(5):753-62
pubmed: 22372830
Bull World Health Organ. 2021 Mar 01;99(3):209-219B
pubmed: 33716343
Bull World Health Organ. 2007 Nov;85(11):880-5
pubmed: 18038079
BMJ Open. 2018 Dec 14;8(12):e024262
pubmed: 30552277
Glob Health Res Policy. 2021 Sep 23;6(1):33
pubmed: 34556184
Ann Intern Med. 2014 Nov 18;161(10):681-9
pubmed: 25402511
PLoS One. 2017 Oct 2;12(10):e0184264
pubmed: 28968435
Curr Med Res Opin. 2017 Feb;33(2):331-358
pubmed: 27819150
Diabetes Res Clin Pract. 2015 Feb;107(2):203-23
pubmed: 25529849
Implement Sci. 2007 Nov 30;2:40
pubmed: 18053122
Curr Opin HIV AIDS. 2016 Jan;11(1):102-8
pubmed: 26545266
PLoS One. 2018 Mar 29;13(3):e0195086
pubmed: 29596495
JMIR Res Protoc. 2022 Sep 2;11(9):e36747
pubmed: 36053576
Health Policy Plan. 2022 Sep 13;37(8):943-951
pubmed: 35262172
BMJ Open. 2023 Jan 12;13(1):e061959
pubmed: 36635032
PLoS One. 2020 Jun 25;15(6):e0235037
pubmed: 32584854
Glob J Health Sci. 2014 Oct 29;7(2):210-27
pubmed: 25716407
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551
PLoS Med. 2019 Mar 1;16(3):e1002751
pubmed: 30822339